Studies in patients with extensively metastatic melanoma, breast cancer, or non-small cell lung cancer (NSCLC) showed an increased expression of the CD158a and CD158b KIR receptors and a negative correlation with NK cell cytotoxicity [24, 25]. Here, KIR2DL3 is linked to non-small cell lung carcinoma.